UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Influenza virus susceptibility and resistance to oseltamivir

Antiviral therapy, 2007-01, Vol.12 (4 Pt B), p.603-616

2007

Link zum Volltext

Verfügbarkeit prüfen

Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial

Clinical infectious diseases, 2006-01, Vol.42 (1), p.8-13

2006

Link zum Volltext

Verfügbarkeit prüfen

Rural practice and the personal and educational characteristics of medical students Survey of 1269 graduates of the University of Manitoba

Canadian family physician, 2012-11, Vol.58 (11), p.e641-e648

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

The New England journal of medicine, 1997-09, Vol.337 (13), p.874-880

1997

Link zum Volltext

Verfügbarkeit prüfen

Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding

Sexually transmitted diseases, 2006-09, Vol.33 (9), p.529-533

2006

Link zum Volltext

Verfügbarkeit prüfen

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

The lancet oncology, 2012, Vol.13 (1), p.100-110

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospects for Control of Herpes Simplex Virus Disease through Immunization

Clinical infectious diseases, 2000-03, Vol.30 (3), p.549-566

2000

Link zum Volltext

Verfügbarkeit prüfen

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

The lancet oncology, 2012, Vol.13 (1), p.89-99

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine

Clinical infectious diseases, 2005-05, Vol.40 (9), p.1271-1281

2005

Link zum Volltext

Verfügbarkeit prüfen

Famciclovir: a focus on efficacy and safety

Expert opinion on drug safety, 2010-07, Vol.9 (4), p.643-658

2010

Link zum Volltext

Verfügbarkeit prüfen

The Use of Antiviral Drugs for Influenza: A Foundation Document for Practitioners

The Canadian journal of infectious diseases & medical microbiology, 2013, Vol.24 (suppl c), p.1-15C

2013

Link zum Volltext

Verfügbarkeit prüfen

Guidance on the use of antiviral drugs for influenza in acute care facilities in Canada, 2014-2015

The Canadian journal of infectious diseases & medical microbiology, 2015-01, Vol.26 (1), p.e5-e8

2015

Link zum Volltext

Verfügbarkeit prüfen

The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013

The Canadian journal of infectious diseases & medical microbiology, 2012, Vol.23 (4), p.e79-e92

2012

Link zum Volltext

Verfügbarkeit prüfen

Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014-2015 season

The Canadian journal of infectious diseases & medical microbiology, 2015-01, Vol.26 (1), p.e1-e4

2015

Link zum Volltext

Verfügbarkeit prüfen

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

The New England journal of medicine, 2002-11, Vol.347 (21), p.1652-1661

2002

Link zum Volltext

Verfügbarkeit prüfen

Clinic-Initiated, Twice-Daily Oral Famciclovir for Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind, Controlled Trial

Clinical infectious diseases, 2005-10, Vol.41 (8), p.1097-1104

2005

Link zum Volltext

Verfügbarkeit prüfen

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

The Journal of infectious diseases, 2014-08, Vol.210 (4), p.517-534

2014

Link zum Volltext

Verfügbarkeit prüfen

The Beneficial Effects of Neuraminidase Inhibitor Drug Therapy on Severe Patient Outcomes During the 2009—2010 Influenza A Virus Subtype H1N1 Pandemic

The Journal of infectious diseases, 2013-02, Vol.207 (4), p.547-549

2013

Link zum Volltext

Verfügbarkeit prüfen

Influenza virus shedding—Excretion patterns and effects of antiviral treatment

Journal of clinical virology, 2009-04, Vol.44 (4), p.255-261

2009

Link zum Volltext

Verfügbarkeit prüfen

An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment

Burns, 2001-11, Vol.27 (7), p.681-688

2001

Link zum Volltext

Verfügbarkeit prüfen

Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients

Therapeutic drug monitoring, 2011-12, Vol.33 (6), p.699

2011

Link zum Volltext

Verfügbarkeit prüfen

The use of antiviral drugs for influenza: recommended guidelines for practitioners

The Canadian journal of infectious diseases & medical microbiology, 2006, Vol.17 (5), p.273-284

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(87)
Buchkapitel
(5)

Sprache

Englisch
(92)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Humans
(61)
Life Sciences & Biomedicine
(61)
Female
(46)
Male
(43)
Adult
(38)
Biological And Medical Sciences
(37)
Medical Sciences
(33)
Infectious Diseases
(27)
Middle Aged
(24)
Pharmacology. Drug Treatments
(22)
Aged
(19)
Pharmacology & Pharmacy
(19)
Antiviral Agents
(18)
Microbiology
(17)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(16)
Adolescent
(15)
General & Internal Medicine
(15)
Infections
(15)
Double-Blind Method
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Influenza virus susceptibility and resistance to oseltamivir

Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial

Rural practice and the personal and educational characteristics of medical students Survey of 1269 graduates of the University of Manitoba

Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections

Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Prospects for Control of Herpes Simplex Virus Disease through Immunization

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine

Famciclovir: a focus on efficacy and safety

The Use of Antiviral Drugs for Influenza: A Foundation Document for Practitioners

Guidance on the use of antiviral drugs for influenza in acute care facilities in Canada, 2014-2015

The use of antiviral drugs for influenza: Guidance for practitioners 2012/2013

Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study

Guidance for practitioners on the use of antiviral drugs to control influenza outbreaks in long-term care facilities in Canada, 2014-2015 season

Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

Clinic-Initiated, Twice-Daily Oral Famciclovir for Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind, Controlled Trial

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA

The Beneficial Effects of Neuraminidase Inhibitor Drug Therapy on Severe Patient Outcomes During the 2009—2010 Influenza A Virus Subtype H1N1 Pandemic

Influenza virus shedding—Excretion patterns and effects of antiviral treatment

An outbreak of methicillin resistant Staphylococcus aureus on a burn unit: potential role of contaminated hydrotherapy equipment

Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients

The use of antiviral drugs for influenza: recommended guidelines for practitioners

Correction: Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study

Suchergebnisse filtern